NOEVIR RAYSELA (NOEVIR USA INC)
Welcome to the PulseAid listing for the NOEVIR RAYSELA drug offered from NOEVIR USA INC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | NOEVIR USA INC |
NON-PROPRIETARY NAME: | ZINC OXIDE, OCTINOXATE, TITANIUM DIOXIDE |
SUBSTANCE NAME: | ZINC OXIDE; OCTINOXATE; TITANIUM DIOXIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2010-01-01 |
END MARKETING DATE: | 0000-00-00 |
NOEVIR RAYSELA HUMAN OTC DRUG Details:
Item Description | NOEVIR RAYSELA from NOEVIR USA INC |
LABELER NAME: | NOEVIR USA INC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 14250; 7500; 2070(mg/100g; mg/100g; mg/100g) |
START MARKETING DATE: | 2010-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62908-011_7eebb3b0-6583-47fe-8679-e894f1740645 |
PRODUCT NDC: | 62908-011 |
APPLICATION NUMBER: | |
Other ZINC OXIDE; OCTINOXATE; TITANIUM DIOXIDE Pharmaceutical Manufacturers / Labelers: